-+ 0.00%
-+ 0.00%
-+ 0.00%

60 DEGREES PHARMACEUTICALS ANNOUNCES EARLY ENROLLMENT OF FIRST SEASONAL PATIENT IN CLINICAL TRIAL OF TAFENOQUINE FOR PATIENTS HOSPITALIZED WITH BABESIOSIS

Reuters·05/26/2026 12:02:00

Please log in to view news